• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Topical cream product for the treatment of skin diseases and obtaining procedure, comprising filamentous vaseline, salicylic acid, mosqueta oil, vitamin a (retinol), enoxolone, distilled water, glycerin and dye, the process consisting of obtaining in the mixture 92.699% of petrolatum filante and 0.05% enoxolone for half an hour; then, 0.05% vitamin a is added and mixed for 10 minutes; then 0.15% of mosqueta oil is added and mixed for 5 minutes; finally, 0.048% distilled water, 0.001% dye, 7.00% salicylic acid and 0.002% glycerin are added and mixed for half an hour. The obtained mixture is allowed to stand for four hours in a refrigerated place before packing. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2551281A1
    申请号:ES201430703
    申请日:2014-05-14
    公开日:2015-11-17
    发明作者:José RAMOS PRIETO
    申请人:José RAMOS PRIETO；
    IPC主号:
    专利说明:

    DESCRIPTIONTopical cream product for the treatment of skin diseases and obtaining procedure.
     5
    OBJECT OF THE INVENTION

    The invention, as expressed in the present specification, refers to a topical cream product for the treatment of skin diseases and method of obtaining. 10

    More particularly, the object of the invention focuses on a product especially indicated for the treatment of psoriasis, dermatitis, acnes, herpes, fungi or other skin diseases by using cream by direct application on the affected area, being a Second aspect of the invention is the process for obtaining said product. fifteen

    FIELD OF APPLICATION OF THE INVENTION

    The field of application of the present invention is part of the industry sector dedicated to the manufacture of cosmetic and pharmaceutical products, and more specifically in the field of the preparation of preparations for the treatment of human skin diseases.

    BACKGROUND OF THE INVENTION
     25
    As a reference to the current state of the art, it should be noted that, although different remedies are known for the treatment of multiple skin conditions, at least by the applicant, the existence of none that has technical, structural characteristics is unknown. and constitutive ones similar to those in particular presented here, as claimed. 30

    EXPLANATION OF THE INVENTION

    The present invention therefore has as its main objective the development of a product that, applied to the areas affected by any of said diseases, allows a cure of skin diseases such as dermatitis, acnes, herpes, fungi, previously mentioned, including Psoriasis, after a certain period of application of the same, as well as the elimination of the symptoms of itching or scaling that are usually associated with these diseases, for which said product, configured as a cream, is topical, the preparation process thereof being the realization of a mixture of the ingredients that compose it by means of a series of combinations carried out in a certain order and under conditions.

    In particular, the recommended product, in a preferred embodiment, comprises the ingredients described below in the indicated proportions:

    - Filament Vaseline ............................................... .................... 92.699%
    - Salicylic acid ............................................... ....................... 7.00%
    - Mosqueta oil .............................................. ................ 0.15%
    - Vitamin A (retinol) ............................................ ................... 0.05% 50
    - Enoxolone ................................................ ............................. 0.05%
    - Distilled water ............................................... ...................... 0.048%
    - Glycerin (E-422) ........................................... ....................... 0.002%
    - Coloring (gentian violet cl4209) .................................. 0.001%

    On the other hand, the product of the previous composition, is obtained based on a procedure that includes the following phases of elaboration:
     5
    - firstly, the filament petrolatum and enoxolone are mixed for half an hour;

    - then, vitamin A is added and mixed for 10 minutes;

    - then add the nutmeg oil and mix for 5 minutes; 10

    - and finally, the rest of the products are added, ie distilled water, dye, salicylic acid and glycerin, and mixed for half an hour;

    - Afterwards, the mixture is allowed to stand for four hours in a refrigerated place before packing.

    Describing sufficiently the nature of the present invention, as well as the way of putting it into practice, it is not considered necessary to extend its explanation so that any expert in the field understands its scope and the advantages that derive from it, 20 stating that , within its essentiality, may be implemented in other embodiments that differ in detail from that indicated by way of example, and which will also achieve the protection sought, provided that it is not altered, changed or modified its fundamental principle.
    权利要求:
    Claims (4)
    [1]

    1.- PRODUCT IN TOPICAL CREAM FOR THE TREATMENT OF SKIN DISEASES, characterized in that it comprises the following ingredients:
    - Filament Vaseline
    - Salicylic acid
    - Mosqueta oil
    - Vitamin A (retinol) 10
    - Enoxolone
    - Distilled water
    - Glycerin (E-422)
    - Colorant
     fifteen
    [2]
    2. PRODUCT IN CREAM OF TOPICAL USE FOR THE TREATMENT OF SKIN DISEASES, according to claim 1, characterized in that the ingredients it comprises are incorporated in the following proportions:
    - Filament Vaseline ............................................... .................... 92.699% 20
    - Salicylic acid ............................................... .................... 7.00%
    - Mosqueta oil .............................................. ............. 0.15%
    - Vitamin A (retinol) ............................................ ................ 0.05%
    - Enoxolone ................................................ ........................... 0.05%
    - Distilled water ............................................... .................... 0.048% 25
    - Glycerin (E-422) ........................................... ..................... 0.002%
    - Colorant................................................ ............................. 0.001%

    [3]
    3. PRODUCT IN CREAM OF TOPICAL USE FOR THE TREATMENT OF SKIN DISEASES, according to claim 1 or 2, characterized in that the dye is gentian violet.

    [4]
    4. PROCEDURE for obtaining a product as described in any of claims 1-3, characterized in that it comprises the following manufacturing phases:
     35
    - Blend Vaseline and enoxolone for half an hour;
    - then, vitamin A is added and mixed for 10 minutes;
    - then add the nutmeg oil and mix for 5 minutes; 40
    - and finally, distilled water, dye, salicylic acid and glycerin are added, and mixed for half an hour;
    - the mixture obtained is allowed to stand for four hours in a refrigerated place before packaging.
    类似技术:
    公开号 | 公开日 | 专利标题
    CL2017001364A1|2017-12-15|New substituted indazoles, procedures for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines.
    BR112016000779A8|2020-01-07|autotaxin inhibitors that comprise heteroaromatic ring benzylamide cycle nucleus, their uses, pharmaceutical composition and combination
    CL2017000475A1|2018-04-27|Compositions for cosmetic formulation comprising a mixture selected from murumuru butter, ucuuba butter, brazilian-nut oil, passion fruit oil, cupuassu butter, assai oil and/or nhandiroba oil and/or esters thereof, as well as the use of a mixture for the preparation of a cosmetic
    BRPI0817262A2|2015-06-16|Biaryl sulphonamide derivatives, pharmaceutical compositions containing them, process for their manufacture, method and uses for the therapeutic and / or prophylactic treatment of diseases and uses in the preparation of medicaments.
    BR112019024747A2|2020-06-09|fixed dose formulations
    DOP2015000005A|2015-02-15|DERIVATIVES OF ESTRA 1,3,5 |, 16 TETRAENE 3 SUBSTITUTES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
    NI201600047A|2016-09-21|HAVE CYCLIC CARBOXAMIDES AND USES OF THE SAME
    GT201700126A|2018-12-06|PIRIDIL-CICLOALQUIL-CARBOXYLIC ACIDS SUBSTITUTED COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME
    WO2017037075A8|2018-04-26|Composition containing echinacea extract and linoleic acid derivatives
    ES2551281B1|2016-09-14|Topical cream product for the treatment of skin diseases and obtaining procedure
    WO2012152940A3|2013-01-03|Small molecule inhibitors of trpa1
    MX2016007973A|2017-07-24|Topical composition comprising natural ingredients for bruising or hematoma healing on skin and use thereof.
    ES2593261B1|2017-07-10|PRODUCT IN CREAM OF TOPICAL USE FOR THE TREATMENT OF SKIN DISEASES AND PROCEDURE OF OBTAINING
    AR108116A1|2018-07-18|DERMOCOSMETIC COMPOSITION, PROCESS OF PRODUCTION OF THE TOPICAL COMPOSITION, METHOD FOR STRENGTHENING OF FRAGILE NAILS AND USE OF COMPOSITION
    CL2017002601A1|2018-04-27|Compositions for long-las¬ting moisturizing cosmetic formulation comprising ucuuba butter with high concentration of myristic acid, as well as the use of said formulation for the preparation of a highly moisturizing cosmetic product and kit
    ES2536661B1|2016-03-09|Protein composition
    BR112019004033A2|2019-05-28|stable oral pharmaceutical composition, process for preparing composition, method, and, use of pharmaceutical composition
    ES2562085B1|2016-07-07|Cream for the treatment of skins with flaking states and manufacturing procedure of said cream
    PL401625A1|2014-05-26|Pharmaceutical composition comprising Roxithromycin, method for manufacture and medical use of the composition and the medicinal product comprising a composition
    ES2554204B1|2016-07-07|Crepe product for people and animals and elaboration process
    AR093070A1|2015-05-13|CRYSTALLINE PHASE OF | 4,4-DISULFANODIILBIS | WITH L-LISINE
    US8501201B1|2013-08-06|Composition useful for improving skin
    Priprem et al.2012|SKIN PERMEATION, SKIN TOXICITY AND ANTI-INFLAMMATION OF HYDROGLYCOLIC EXTRACT FROM MYROBALAN FRUITS
    BR112015012960A2|2017-07-11|oral gel for toothache relief
    UA107917U|2016-06-24|COMPOSITION PHYTOPREAD FOR THE TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL TISSUES IN CHILDREN
    同族专利:
    公开号 | 公开日
    ES2551281B1|2016-09-14|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR2837704A1|2002-04-02|2003-10-03|Oreal|Use of sapogenins or compositions or natural extracts containing them to treat dry skin or scalp or associated disorders|
    JP2009046468A|2007-07-23|2009-03-05|Rohto Pharmaceut Co Ltd|Skin care preparation for external use for wet skin|
    WO2009022041A1|2007-08-13|2009-02-19|Ramos Prieto Jose|Ointment for controlling and treating skin diseases and preparation method therefor|
    US20120189684A1|2009-07-17|2012-07-26|Reckitt Benckiser Healthcare International Limited|Skincare Compositions|
    EP2387990A1|2010-05-06|2011-11-23|Skinius S.R.L.|Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies|
    BRPI1104422A2|2011-09-05|2014-03-18|Riformula Farmacia De Manipulacao Ltda Me|DERMATOLOGICAL COMPOSITION FOR TREATMENT OF TOPICAL USE PSORIASIS|
    CN102688168A|2012-06-06|2012-09-26|南通恒隆化工有限公司|Waterproof cold cream|
    WO2014036620A1|2012-09-04|2014-03-13|Trassi Antonio Jose|Process for manufacturing a product for treating psoriasis and product for treating psoriasis|
    CN102908291A|2012-11-13|2013-02-06|沈阳信达信息科技有限公司|Hand cream containing angelica sinensis|ES2593261A1|2016-10-03|2016-12-07|José RAMOS PRIETO|Product in cream of topical use for the treatment of skin diseases and procedure of obtaining |
    法律状态:
    2016-09-14| FG2A| Definitive protection|Ref document number: 2551281 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160914 |
    2021-09-15| FD2A| Announcement of lapse in spain|Effective date: 20210915 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201430703A|ES2551281B1|2014-05-14|2014-05-14|Topical cream product for the treatment of skin diseases and obtaining procedure|ES201430703A| ES2551281B1|2014-05-14|2014-05-14|Topical cream product for the treatment of skin diseases and obtaining procedure|
    [返回顶部]